Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Jazz Pharmaceuticals

    NASDAQ: JAZZ · Real-Time Price · USD
    109.64
    1.14 (1.05%)
    At close: Jun 16, 2025, 3:59 PM
    109.61
    -0.03%
    Pre-market: Jun 17, 2025, 07:00 AM EDT

    Jazz Pharmaceuticals Statistics

    Share Statistics

    Jazz Pharmaceuticals has 60.51M shares outstanding. The number of shares has increased by -3.69% in one year.

    Shares Outstanding

    n/a
    		 60.51M

    Shares Change (YoY)

    n/a
    		 -3.69%

    Shares Change (QoQ)

    n/a
    		 0.46%

    Owned by Institutions (%)

    n/a
    		 96.17%

    Shares Floating

    n/a
    		 57.66M

    Failed to Deliver (FTD) Shares

    n/a
    		 14,644

    FTD / Avg. Volume

    n/a
    		 1.17%

    Short Selling Information

    The latest short interest is 5.71M, so 9.27% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.71M

    Short % of Shares Out

    n/a
    		 9.27%

    Short % of Float

    n/a
    		 10.68%

    Short Ratio (days to cover)

    n/a
    		 5.8

    Valuation Ratios

    The PE ratio is 13.6 and the forward PE ratio is 5.02. Jazz Pharmaceuticals's PEG ratio is 0.45.

    PE Ratio

    n/a
    		 13.6

    Forward PE

    n/a
    		 5.02

    PS Ratio

    n/a
    		 1.87

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 1.86

    P/FCF Ratio

    n/a
    		 5.65

    PEG Ratio

    n/a
    		 0.45
    Financial Ratio History

    Enterprise Valuation

    Jazz Pharmaceuticals has an Enterprise Value (EV) of 11.36B.

    EV / Sales

    n/a
    		 2.79

    EV / EBITDA

    n/a
    		 8.3

    EV / EBIT

    n/a
    		 8.14

    EV / FCF

    n/a
    		 8.43

    Financial Position

    The company has a current ratio of 4.46, with a Debt / Equity ratio of 1.51.

    Current Ratio

    n/a
    		 4.46

    Quick Ratio

    n/a
    		 3.99

    Debt / Equity

    n/a
    		 1.51

    Debt / EBITDA

    n/a
    		 4.5

    Debt / FCF

    n/a
    		 4.57

    Interest Coverage

    n/a
    		 3.01

    Financial Efficiency

    Return on Equity is 13.68% and Return on Invested Capital is 7.74%.

    Return on Equity

    n/a
    		 13.68%

    Return on Assets

    n/a
    		 4.66%

    Return on Invested Capital

    n/a
    		 7.74%

    Revenue Per Employee

    n/a
    		 $1,453,196.43

    Profits Per Employee

    n/a
    		 $200,042.86

    Employee Count

    n/a
    		 2,800

    Asset Turnover

    n/a
    		 0.34

    Inventory Turnover

    n/a
    		 0.93

    Taxes

    Income Tax

    n/a
    		 -89.77M

    Effective Tax Rate

    n/a
    		 -19.09%

    Stock Price Statistics

    The stock price has increased by -4.27% in the last 52 weeks. The beta is 0.33, so Jazz Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.33

    52-Week Price Change

    n/a
    		 -4.27%

    50-Day Moving Average

    n/a
    		 107.95

    200-Day Moving Average

    n/a
    		 118.33

    Relative Strength Index (RSI)

    n/a
    		 49.76

    Average Volume (20 Days)

    n/a
    		 1,253,736

    Income Statement

    In the last 12 months, Jazz Pharmaceuticals had revenue of 4.07B and earned 560.12M in profits. Earnings per share was 9.06.

    Revenue

    n/a
    		 4.07B

    Gross Profit

    n/a
    		 3.62B

    Operating Income

    n/a
    		 716.63M

    Net Income

    n/a
    		 560.12M

    EBITDA

    n/a
    		 1.37B

    EBIT

    n/a
    		 708.45M

    Earnings Per Share (EPS)

    n/a
    		 9.06
    Full Income Statement

    Balance Sheet

    The company has 2.41B in cash and 6.16B in debt, giving a net cash position of -3.75B.

    Cash & Cash Equivalents

    n/a
    		 2.41B

    Total Debt

    n/a
    		 6.16B

    Net Cash

    n/a
    		 -3.75B

    Retained Earnings

    n/a
    		 1.13B

    Total Assets

    n/a
    		 11.53B

    Working Capital

    n/a
    		 2.91B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 1.4B and capital expenditures -48.07M, giving a free cash flow of 1.35B.

    Operating Cash Flow

    n/a
    		 1.4B

    Capital Expenditures

    n/a
    		 -48.07M

    Free Cash Flow

    n/a
    		 1.35B

    FCF Per Share

    n/a
    		 21.8
    Full Cash Flow Statement

    Margins

    Gross margin is 89.05%, with operating and profit margins of 17.61% and 13.77%.

    Gross Margin

    n/a
    		 89.05%

    Operating Margin

    n/a
    		 17.61%

    Pretax Margin

    n/a
    		 11.56%

    Profit Margin

    n/a
    		 13.77%

    EBITDA Margin

    n/a
    		 33.63%

    EBIT Margin

    n/a
    		 17.61%

    FCF Margin

    n/a
    		 33.12%

    Dividends & Yields

    JAZZ does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 7.36%

    FCF Yield

    n/a
    		 17.7%
    Dividend Details

    Analyst Forecast

    The average price target for JAZZ is $175.5, which is 60.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $175.5

    Price Target Difference

    n/a
    		 60.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 12
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $146.59

    Lynch Upside

    n/a
    		 33.7%

    Graham Number

    n/a
    		 116.15

    Graham Upside

    n/a
    		 5.94%

    Scores

    Altman Z-Score

    n/a
    		 1.51

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist